Medvest Capital

Medvest Capital operates as a venture capital firm dedicated to investing in and nurturing early-stage medical device companies. Beyond providing essential capital, the firm actively collaborates with portfolio management, offering strategic guidance to validate market feasibility, accelerate product development, and instill the robust business processes necessary for sustained expansion. This hands-on approach aims to cultivate innovative solutions within the healthcare technology sector.

Founded in 2013 by Managing Partner David Cash, Medvest Capital emerged from a foundational insight focused on improving patient outcomes, decreasing delivery costs, and minimizing provider risk. Cash brought significant prior experience in healthcare real estate development and finance, having established Stanmore Development and previously serving as a financial analyst at CIBC World Markets, shaping the firm's strategic investment philosophy.

The firm's clients are early-stage medical device companies seeking both financial backing and strategic operational support. Medvest Capital’s long-term vision centers on fostering innovation that enhances healthcare efficiency and patient well-being, ultimately driving the development of medical technologies poised to address critical industry challenges and advance patient care.